Pharma penny stock under Rs 60 in green after bagging new order worth USD 23,000 from FIRSTVET Veterinary Medicines Trading LLC Pharma penny stock under Rs 60 in green after bagging new order worth USD 23,000 from FIRSTVET Veterinary Medicines Trading LLC The stock is up 40.14 per cent from its 52-week low of Rs 41.10 per share. Kiran Shroff / Thursday, December 26, 2024 0 92 Article rating: 3.9 The shares of the company have an ROE of 25 per cent and an ROCE of 32 per cent. Read more
Pharma Penny Stock Under Rs 60 In Green After Bagging A Significant New Order Worth Rs 6,28,15,000 Pharma Penny Stock Under Rs 60 In Green After Bagging A Significant New Order Worth Rs 6,28,15,000 The company has a market cap of Rs 63 crore and on Tuesday, the stock was trading at Rs 53.80 per share on NSE. Kiran Shroff / Tuesday, November 19, 2024 0 244 Article rating: 4.0 The company has a market cap of Rs 63 crore and on Tuesday, the stock was trading at Rs 53.80 per share on NSE. Read more
Pharma penny stock under Rs 55 in green as company bags new order worth USD 19,200 from Genet International & FIRSTVET Veterinary Medicines Trading LLC Pharma penny stock under Rs 55 in green as company bags new order worth USD 19,200 from Genet International & FIRSTVET Veterinary Medicines Trading LLC The shares of the company have an ROE of 25 per cent and an ROCE of 32 per cent. Kiran Shroff / Wednesday, October 30, 2024 1 999 Article rating: 3.5 The stock is up 34.21 per cent from its 52-week low of Rs 38.01 per share. Read more
Penny stock below Rs 50 jumps over 10 per cent as pharma company bags new order worth USD 17,700 from Al-Saqr Agro For Agricultural And Veterinary Entries Penny stock below Rs 50 jumps over 10 per cent as pharma company bags new order worth USD 17,700 from Al-Saqr Agro For Agricultural And Veterinary Entries The shares of the company have an ROE of 25 per cent and an ROCE of 32 per cent. Kiran Shroff / Thursday, September 19, 2024 0 510 Article rating: 3.9 The stock is up 30 per cent from its 52-week low of Rs 37.50 per share. Read more
230 per cent returns: This multibagger pharmaceutical company announced approval for a new drug from US FDA; do you own it? 230 per cent returns: This multibagger pharmaceutical company announced approval for a new drug from US FDA; do you own it? The company has delivered returns of 14.5 per cent over the past 3 years and returns of 230 per cent over the past 5 years. Siddharth Mane / Friday, July 14, 2023 0 14417 Article rating: 4.1 The company has a ROCE of 19.4 per cent and a ROE of 19.1 per cent. Read more